CMS has posted revised Medicare gapfill prices, including the 2014 National Limit Amount (NLA), for new molecular pathology codes under the Medicare Clinical Laboratory Fee Schedule (CLFS). CMS will accept reconsideration requests untilOctober 30, 2013. If CMS revises any NLA under the reconsideration process, the revised NLA will be the upper payment limit effective January 1, 2014. Once the reconsideration process is completed, the determination will be final and not be subject to further reconsideration.
- How-to guide How-to guide: How to comply with data processing principles under the GDPR (EU)
- Checklist Checklist: FCPA due diligence of third-party intermediaries (USA)
- How-to guide How-to guide: Understanding antitrust and unfair trade practices law and your organization’s compliance obligations (USA)